Supreme Court Initiates Suo Motu Probe Into Life-Saving Drug Prices

The Supreme Court of India has taken suo motu cognisance of a case concerning the high cost of life-saving medicines. The court acted following the death of a breast cancer patient from Kerala who had challenged the prohibitive pricing of essential treatments in the state's High Court. This legal move underscores the rising national concern over the accessibility and affordability of critical life-saving drugs within the Indian healthcare framework.

The petitioner, who tragically passed away while her plea was pending in the Kerala High Court, had sought relief from the financial burden imposed by exorbitant drug costs. This case highlights a persistent systemic issue where patients often struggle to afford life-sustaining treatments, forcing them to turn to judicial authorities for intervention. Similar cases have previously prompted debates regarding the implementation of the Drug Price Control Order and the broader regulation of pharmaceutical manufacturing costs to protect vulnerable patients.

The Supreme Court's intervention signals a potential shift in how drug pricing might be regulated to ensure wider access for patients suffering from terminal illnesses. By taking cognisance of the matter, the court may now evaluate the efficacy of existing price-capping mechanisms and the role of the government in subsidizing essential medical supplies. This development is being closely watched by civil society groups, as a final verdict could mandate stricter price controls on vital medications, potentially reducing the out-of-pocket medical expenditure for millions of Indian citizens.